The Pfizer Research Grant Request supports research studies focused on generating evidence regarding the use of elranatamab in Multiple Myeloma (MM) within real-world or clinical practice settings.

Overview

This competitive grant program seeks to generate robust evidence on the effectiveness and safety of elranatamab in routine clinical practice for patients with relapsed or refractory multiple myeloma (RRMM). Given the limited real-world experience in treating triple-class-exposed (TCE) RRMM following the recent approval of elranatamab, real-world data are needed.

Projects considered for support will focus on several key areas:

• Real-world evidence (RWE) and observational studies assessing safety, effectiveness, and treatment patterns.
• Comparative and sequencing analyses evaluating outcomes across prior therapies and lines of treatment.
• Subgroup and disparity research focused on populations underrepresented in clinical trials.
• Patient-centered outcomes research, including Patient-Reported Outcomes (PROs), caregiver burden, and adherence.
• Translational and biomarker research to understand mechanisms of response, resistance, and relapse.

Eligibility

The following criteria apply to potential applicants:

• Geographic Scope: Spain.
• Applicant Eligibility: Only organizations are eligible to receive grants; individuals or medical practice groups are not eligible.
• Principal Investigator (PI) Requirements: The PI must possess a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with an MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work. The PI must be an employee or contractor of the requesting organization.
• Institutional Requirements: The institution and PI must be based in Spain. If the project involves multiple departments or institutions, all must have a relevant role, and the requesting organization must have a key role.
• Funding Capacity: The requesting organization must be legally able to receive award funding directly from Pfizer International LLC.

Funding and Project Scope

The total available budget related to this Request for Proposals (RFP) is approximately 250,000€.

• Individual projects requesting up to 120,000€ will be considered, though smaller requests (around 60,000) are also welcome.
• The anticipated project duration is not specified, but the submission process requires detailed planning.

Submission Guidelines

Interested parties must adhere to the following submission requirements:

• The application must be submitted via the designated online portal.
• The proposal must include a detailed methodology, expected outcomes, and a comprehensive budget breakdown.
• All submissions must be reviewed against the criteria outlined in the official guidelines.

Key Dates

Please note the following timeline:

• Submission Deadline: [Insert Date]
• Notification of Award: [Insert Date]